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We report here initial studies on phosphoenolpyruvate metabolism in coupled mitochondria isolated from Jerusalem artichoke tubers. It was
found that:
(1) phosphoenolpyruvate can be metabolized by Jerusalem artichoke mitochondria by virtue of the presence of the mitochondrial pyruvate kinase,
shown both immunologically and functionally, located in the inner mitochondrial compartments and distinct from the cytosolic pyruvate kinase
as shown by the different pH and inhibition profiles.
(2) Jerusalem artichoke mitochondria can take up externally added phosphoenolpyruvate in a proton compensated manner, in a carrier-mediated
process which was investigated by measuring fluorimetrically the oxidation of intramitochondrial pyridine nucleotide which occurs as a result of
phosphoenolpyruvate uptake and alternative oxidase activation.
(3) The addition of phosphoenolpyruvate causes pyruvate and ATP production, as monitored via HPLC, with their efflux into the
extramitochondrial phase investigated fluorimetrically. Such an efflux occurs via the putative phosphoenolpyruvate/pyruvate and
phosphoenolpyruvate/ATP antiporters, which differ from each other and from the pyruvate and the adenine nucleotide carriers, in the light
of the different sensitivity to non-penetrant compounds. These carriers were shown to regulate the rate of efflux of both pyruvate and ATP. The
appearance of citrate and oxaloacetate outside mitochondria was also found as a result of phosphoenolpyruvate addition.
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One of the most outstanding problems in plant bioenergetics
concerns the fuelling of mitochondria in plant cells oxidizing
carbohydrate. In addition to that metabolized in the methyl-
glyoxal pathway which results in the formation of D-lactate
[1,2], glucose is also converted by glycolysis to phosphoenol-
pyruvate (PEP) and finally to pyruvate via the cytosolic pyruvate
kinase. Pyruvate kinase (PK) is an important regulatory enzyme
of glycolysis that catalyzes the irreversible substrate level
phosphorylation of ADP at the expense of PEP, yielding
pyruvate and ATP. Plant PK is a primary site of control of
glycolytic flux for pyruvate [3]. On the other hand, several
conditions including high cytosolic energy charge [4,5], the
presence of negative modulators such as glutamate [6–10] and
citrate [11] and the decline in phosphate and ADP [12] cellular
concentrations can severely limit PK activity thus causing PEP
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considered to compensate for limited pyruvate formation and
transport across the mitochondrial membrane [13,14]; in this
pathway, pyruvate enters mitochondria in form of malate
following the combined action of the cytosolic phosphoenolpyr-
uvate carboxylase (PEPC) and malate dehydrogenase, malate
translocators and mitochondrial malic enzyme (ME) (see
Scheme 1) [13,15–17].
Since it was found that all glycolytic enzymes are functionally
associated with mitochondria from Arabidopsis, the possibility
that mitochondria possess their own PK should be taken inScheme 1. PEP transport and metabolism in JAM. For explanation see the text. Abb
alanine; OAA, oxaloacetate; MAL, malate; CITR, citrate; ISOC, isocitrate; HS-CoA,
α-oxoglutarate; Pi, inorganic phosphate; MIM, mitochondrial inner membrane; MO
mPK, cytosolic, mitochondrial pyruvate kinase; mMDH, cMDH, cytosolic, mitochon
phosphoenolpyruvate carboxylase; cME, mME, cytosolic, mitochondrial malic en
transaminase; AAT, aspartate amino transaminase; cACO, cytosolic aconitase; cIso-D
dehydrogenase; I, complex I of the respiratory chain; Q, coenzyme Q; AOX, alternat
antiporter; P, pyruvate carrier; D, dicarboxylate carrier; ?, PEP transporters.consideration. In this regard, PK was reported to have one
isoform predicted to be targeted to mitochondria [18]. Con-
sistently, a gene search for PK in TAIR database (Arabidopsis
Information Resource) identified two matches (AT3G25960 and
AT3G55810) which correspond to isoforms predicted by Target
P program to be targeted to mitochondria.
All together the above considerations show that the interaction
between glycolysis intermediates and energy metabolism in
mitochondria is far from being established. In particular, the
capability of glycolytic compounds including PEP to enter and to
be metabolized in the mitochondria is far from being elucidated.reviations used in the figure: PEP, phosphoenolpyruvate; PYR, pyruvate; ALA,
coenzyme A; Ac-SCoA, acetyl-SCoA; GLU, glutamate; ASP, aspartate; α-OG,
M, mitochondrial outer membrane; IMS, intermembrane space; enzymes: cPK,
drial malate dehydrogenase; PEPase, phosphoenolpyruvate phosphatase; PEP-C,
zyme; PYR-DH, pyruvate dehydrogenase complex; GPT, glutamate pyruvate
H, cytosolic isocitrate dehydrogenase; CL, citrate lyase; iND, internal NAD(P)H
ive oxidase; carriers: 1, PEP/H+ symporter; 2, PEP/ATP antiporter; 3, PEP/PYR
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Jerusalem artichoke, used as a model system, can metabolize
externally added PEP, perhaps triggering a novel mitochon-
drion–cytosol crosstalk. We report both immunological and
functional evidence of the existence of a mitochondrial PK
which charges mitochondria with pyruvate and ATP thus
promoting novel metabolite traffic across the mitochondrial
membranes and which may be involved in cytosolic biosyn-
thetic processes. Interestingly, PEP appears to be a novel
alternative oxidase activator.
2. Materials and methods
2.1. Materials
All reagents were from SIGMAwith the exception of sucrose, Triton X-100,
HEPES, Tris and sodium arsenite (Baker).
All chemicals were of purest grade available and were used as Tris salts at
pH 7.0–7.4 adjusted with Tris or HCl. Rotenone, oligomycin and FCCP were
dissolved in ethanol.
Jerusalem artichoke tubers were kindly supplied by Prof. A. De Santis
(Università Politecnica delle Marche).
2.2. Isolation of JAM and preparation of the cytosolic fraction
Jerusalem artichoke mitochondria (JAM) were isolated as in [19] and
checked for their intactness [20,21]. Mitochondria showing intactness lower
than 90 and 95% for the outer and inner membranes respectively were discarded.
Mitochondrial coupling was also checked: JAM showed respiratory control
equal to 2.6±0.24 as in [22].
The cytosolic fraction (CF) was obtained by centrifuging (105,000×g for
60 min at 4 °C) the supernatant obtained during isolation of JAM. Glucose-6-
phosphate dehydrogenase (G6PDH) (E.C. 1.1.1.49) and adenylate kinase
(ADK) (E.C. 2.7.4.3.), cytosolic and mitochondrial markers, respectively, were
assayed as in [23] and [24].
2.3. Immunoblot analysis
Immunoblot analysis was performed on either total mitochondrial or total
cytosolic protein by using antibodies raised against PK and β-tubulin.
Polyclonal antibody recognizing β-tubulin was used as a marker of cytosol.
Both JAM and CF were solubilized in Triton X-100 (TX-100, 1%), 500 mM
NaCl, 50 mM Tris–HCl pH 7.5, 1 mM EGTA, 1 mM EDTA, 0.5 mM
dithiothreitol, 0.1 mM PMSF for 30 min on ice. Protein content was determined
using the Bradford reagent (Bio-Rad Laboratories) with bovine serum albumin
(BSA) as a standard. Both mitochondrial and cytosolic solubilized proteins
(40 μg each) were subjected to electrophoresis on 12% SDS-polyacrylamide gel
[25]. Following electrophoresis, protein blots were transferred to a PVDF
membrane. The membrane was blocked with 5% non-fat milk in TBS solution,
and incubated overnight with the corresponding primary antibodies in the
blocking solution at 4 °C. After washing three times with TBS-T solution
(0.3%), the membrane was incubated at room temperature for 1 h with HRP-
conjugated secondary antibody. The detected protein signals were visualized by
using the Enhanced Chemiluminescence Western Blotting reagents
(Amersham).
2.4. Pyruvate kinase assay
Because the external mitochondrial NAD(P)H dehydrogenase rapidly
oxidizes NADH used in the PK assay via L-lactate dehydrogenase (L-LDH),
PK activity was mostly monitored by measuring the rate of ATP formation,
revealed by using the ATP detecting system (ATP D.S.) consisting of glucose
(2.5 mM), hexokinase (HK, 0.5 e.u.), G6PDH (0.5 e.u.) and NADP+ (0.2 mM).
The detection was done fluorimetrically at the excitation-emission wavelengths
of 334–456 nm as in [26,27] using a Perkin Elmer LS-50 luminometer, withthe NAD(P)H fluorescence calibrated as described in [28–30]. Briefly, either
the cytosol fraction (0.2 mg of cytosol protein) or JAM (0.5 mg of
mitochondrial protein), in the absence or presence of TX-100 (0.2%), was
incubated at 25 °C in 2 mL of standard medium consisting of 0.29 mM
sucrose, 20 mM KCl, 20 mM HEPES–Tris pH 7.0, 10 mM MgCl2, in the
presence of ATP D.S. Where indicated, 0.1 mM P1,P5-di(adenosine-5′)
pentaphosphate (Ap5A), a specific inhibitor of ADK [31] was also added. The
reaction was started by the addition of either PEP or ADP at the concentrations
reported in the legends of the relevant figures, in the presence of 0.25 mM
ADP or 5 mM PEP, respectively. The rate of NADP+ reduction was followed
as fluorescence increase and measured as the tangent to the initial part of the
progress curve. The specific activity was expressed as nmol NADP+ reduced/
min×mg cytosol or mitochondrial protein. Control experiments confirmed that
none of the compounds used in this paper affects the enzymes used to reveal
pyruvate kinase activity.
When pyruvate production was measured (as in [4]) NADH (0.1 mM) plus
L-lactate dehydrogenase (L-LDH) (1 e.u.) were used in the presence of EGTA
(10 mM) plus diphenyleneiodonium (DPI, 5 μM) and rotenone (ROT, 2 μg),
used to inhibit oxidation of externally added NADH by JAM. The rate of NADH
oxidation by pyruvate was corrected for the spontaneous NADH oxidation by
JAM.
2.5. Swelling experiments
Mitochondrial swelling was followed at 25 °C at 546 nm using a Perkin-
Elmer Lambda-5 spectrophotometer. JAM (1 mg protein) were rapidly added to
1.5 mL of isotonic solutions of ammonia salts whose pH was adjusted to 7.2, and
the decrease in the absorbance continuously recorded.
2.6. Fluorimetric and photometric assays
Changes in the redox state of mitochondrial pyridine nucleotides were
monitored fluorimetrically, using a Perkin Elmer luminometer LS-50 with
excitation–emission wavelengths of 334–456 nm. The NAD(P)H fluorescence
was calibrated as in [28–30]. JAM (1 mg protein) were incubated in 2 mL of
standard medium and the fluorescence changes monitored as a function of time.
PEP uptake was monitored by measuring the intramitochondrial NAD(P)H
oxidation caused by externally adding the substrate to JAM.
ATP, pyruvate, oxaloacetate (OAA) and citrate appearance outside
mitochondria was monitored by using the ATP D.S. in the presence of
Ap5A (0.1 mM) and succinate (5 mM) used to energize mitochondria, the
pyruvate detecting system (P.D.S.) consisting of 20 μM NADH plus L-LDH
(1 e.u.), the oxaloacetate detecting system (O.D.S.) consisting of 20 μM
NADH plus malate dehydrogenase (1 e.u.) and the citrate detecting system
(C.D.S.) consisting of O.D.S. plus citrate lyase (1 e.u.), ATP (1 mM) and
coenzyme A (1 mM). When either pyruvate, oxaloacetate or citrate efflux was
monitored, JAM were pre-incubated in the presence of EGTA (10 mM) plus
diphenyleneiodonium chloride (DPI) (5 μM) and ROT (2 μg), used to prevent
oxidation of externally added NADH by both the external mitochondrial
NAD(P)H dehydrogenase and complex I of respiratory chain, respectively.
The decreased NADH concentration (20 μM instead of 0.1 mM) used to
reveal pyruvate appearance outside intact mitochondria was necessary to
prevent NADH oxidation by external NADH-DH which was not completely
inhibited by the presence of rotenone/EGTA/DPI. It was established that
under these conditions the activity of the P.D.S. was not limiting in
determining the rate of pyruvate production.
The reduction of NADP+ in the case of ATP, or the oxidation of NADH in
the case of either pyruvate, oxaloacetate or citrate, consequent on PEP addition
to JAM, was followed as either fluorescence increase or decrease, measured as
the tangent to the initial part of the progress curve and expressed as nmol
NADP+ reduced (NADH oxidized)/min×mg mitochondrial protein, respec-
tively. Citrate appearance rate was calculated by subtracting the rate of
oxaloacetate appearance from the rate of absorbance decrease found in the
presence of the C.D.S. In the case of ADP/ATP carrier measurement, ADP was
added to JAM at the concentrations reported in the relevant Figs, under the same
experimental conditions used for the detection of PEP-dependent ATP efflux.
Malate appearance was monitored photometrically as in [2] by following the
absorbance increase at the wavelength of 334 nm in the presence of the malate
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(ME, 0.2 u.e). The value of ε334 measured for NAD(P)H under our experimental
conditions was found to be 6.22 mM−1 cm−1.
PEP per se proved to have no effect on the enzymatic reactions or on either
the absorbance or the fluorescence measured. Moreover, controls were carried
out to ensure that none of the compounds used affected the enzymes used to
reveal metabolite appearance outside mitochondria.
2.7. HPLC measurements
All the measurements were carried out by means of a Kontron Instrument
HPLC system including a model 420 pump and a model 425 gradient former
equipped with a data system 450 MT2. In a typical experiment, JAM (1 mg
protein) were incubated for 1min in 1mL of standardmedium plus 0.1mMAp5A
and then PEP (5 mM) was added either in the absence or presence of oligomycin
(OLIGO, 2.5 μg/mL). After 1 min of incubation the suspension was rapidly
centrifuged for 1 min at 13000 rpm in a refrigerated Eppendorf microcentrifuge.
Perchloric acid extracts of both supernatant and pellet were obtained and
neutralized as in [32]. In order to determine the amount of ADP and ATP, aliquots
of the neutralized perchloric acid extracts were analyzed by means of HPLC as
previously reported [33], with a calibration made in each experiment.Fig. 1. Immunodetection of mitochondrial PK and pyruvate kinase activity assay in J
analyzed by Western blotting as described in Materials and methods. Membrane blots
was used as a cytosolicmarker. (B) Either JAM (0.5mgmitochondrial protein) (a) or C
detergent TX-100 (0.2%) in 2 mL of standard medium in the presence of ATP D.S. W
and PEP (5mM)were added.Where indicated,MALO (10mM)was added 1min befo
or presence of the detergent. PK activity was monitored fluorimetrically at the excitati
along curves are rates of fluorescence increase measured as the tangents to the initia
sample protein. Insets report either TX-JAM (1mg protein, inset a) or CF (1mg protein
When indicated, ADP (0.25 mM) was also present. At the arrow, PEP (5 mM) was ad
either TX-JAM or CF. PK activity was monitored photometrically at 334 nm (see M
measured as the tangents to the initial part of the progress curve and expressed as nm3. Results
3.1. The occurrence of pyruvate kinase activity in solubilized
mitochondria from Jerusalem artichoke tubers
In order to ascertain whether JAM can metabolize externally
added PEP, first we investigated the occurrence of PK in
coupled JAM (Fig. 1A). An immunological analysis carried out
by using anti-PK antibodies showed the occurrence of the
mitochondrial PK. Each mitochondrial sample was also
subjected to Western blotting for β-tubulin, as a cytosolic
marker, using a polyclonal anti-β-tubulin antibody; JAM were
found to be completely free of cytosolic contamination since no
β-tubulin was detected. The immunological analysis of the
cytosolic fraction of the same preparation, used as a control,
showed the presence of both cytosolic PK and β-tubulin.
The existence of a putative mitochondrial PK protein was
confirmed by measurement of the reaction catalyzed by PK inAM and CF. (A) Solubilized proteins from both JAM and CF (40 μg each) were
were incubated with polyclonal anti-PK and anti-β-tubulin antibodies. β-tubulin
F (0.2mg protein) (b) were incubated at 25 °C in the absence (C) or presence of the
hen indicated, 0.1 mM Ap5Awas also present (a). At the arrow, ADP (0.25 mM)
re the substrates to either JAM solubilized with TX-100 or CF either in the absence
on–emission wavelength of 334–456 nm (see Materials and methods). Numbers
l part of the progress curve and expressed as nmol NADP+ reduced/min×mg of
, inset b) incubated at 25 °C in 2mL of standard medium in the presence of P.D.S.
ded. Where indicated, MALO (10 mM) was added 1 min before PEP addition to
aterials and methods). Numbers along curves are rates of absorbance decrease
ol NADH oxidized/min×mg of sample protein.
Fig. 2. The dependence of ATP and pyruvate appearance on increasing
concentrations of either PEP or ADP. (A) PEP at 0.25 mM ADP, or (B) ADP at
5 mM PEP, were added at the indicated concentrations to either TX-JAM
(0.5 mg mitochondrial protein) (Δ, ●) or CF (0.2 mg cytosol protein) (○) and
either ATP (●, ○) or pyruvate (Δ) appearance was investigated as described in
Materials and methods. The rate (Vo) of NADP
+ reduction (●, ○) or NADH
oxidation (Δ) was calculated as the tangent to the initial part of the progress
curve and expressed as nmol/min×mg of sample protein. Bars represent the
mean (±SD) of three independent measurements.
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examined. This was done fluorimetrically, by measuring the
pyridine nucleotide fluorescence increase, which occurs as a
result of appearance of ATP (one of the product of the PK
reaction) as detected by the presence of glucose, HK, G6PDH
and NADP+ (the ATP D.S.) plus 0.25 mM ADP and 0.1 mM
Ap5A, used to inhibit ADK [31] (Fig. 1B, a). The CF of the
same preparation was used as a control, but in this case no
Ap5Awas present (Fig. 1B, b). ATP concentration outside intact
JAM (0.5 mg mitochondrial protein) and in the CF (0.2 mg
cytosol protein) was negligible since no fluorescence change
was found in the presence of ATP D.S. No increase in NADPH
fluorescence was found when ADP (0.25 mM) was added, this
showing the complete inhibition of ADK activity in the
mitochondrial preparation (Fig. 1B, a). As a result of PEP
addition to intact JAM no significant fluorescence change was
found, this indicating the absence of PK in the outer membrane,
in the intermembrane space or on the outer side of the
mitochondrial inner membrane and excluding any contamina-
tion of the mitochondrial fraction with the cytosolic PK (Fig.
1B, a). In a control experiment, no G6PDH activity, measured
as in [23], was found either in intact or solubilized JAM thus
further confirming the absence of cytosolic contamination;
conversely, no ADK activity, a mitochondrial inter-membrane
space marker, measured as in [24], was found in the CF, thus
excluding both the presence of mitochondrial contamination
and of mitochondrial outer membrane rupture (Fig. 1B, b).
Surprisingly enough, when the membrane detergent Triton
X-100 (TX-100, 0.2%) was added to JAM (0.5 mg mitochon-
drial protein) in order to dissolve the mitochondrial membranes,
NADPH formation was found following PEP (5 mM) addition
with a rate of 16 nmol NADP+ reduced/min×mg of mitochon-
drial protein (Fig. 1B, a). As expected, an increase in NADPH
fluorescence was observed when PEP (5 mM) was added to the
CF, reflecting the activity of the cytosolic PK and found to be
equal to 10 nmol NADP+ reduced /min×mg of cytosol protein
both in the absence and presence of TX-100 (0.2%) (Fig. 1B, b).
Interestingly, in distinction with the CF, no fluorescence increase
was foundwhen JAM solubilized with 0.2%TX- 100 (TX-JAM)
were incubated with malonate (MALO, 10mM) for 1 min before
PEP addition. (Fig. 1B, a and b). As expected, no PK activity was
measured when both mitochondrial and cytosolic samples were
boiled to denaturate the proteins (not shown). In agreement with
the above findings, as a result of the addition of PEP to TX-JAM
(1 mg mitochondrial protein), pyruvate formation was found
occurring at the same rate as that of ATP production, and was
completely prevented by MALO (10 mM) (inset to Fig. 1B, a).
Pyruvate formation, as checked in CF, was not sensitive to
MALO, either in the absence or presence of ADP (inset to Fig.
1B, b).
The dependence of the rate of NADP+ reduction on
increasing PEP (at 0.25 mM ADP) (Fig. 2A) or ADP
concentrations (at 5 mM PEP) (Fig. 2B) was investigated in
TX-JAM (●) and in CF (○). In both cases saturation
characteristics were found with Km(PEP) values of 200 and
500 μM and Km(ADP) values of 60 and 40 μM, for TX-JAM
and CF, respectively; Vmax values were of 16 and 12 nmol/min×mg of sample protein, respectively, with both substrates. In
three experiments, carried out with different TX-JAM and CF
preparations, the mean Km(PEP) values were found to be 200±
20 μM and 500±20 μM, whereas the mean Km(ADP) values
were found to be 60±5 μM and 40±4 μM, for the mitochon-
drial and cytosolic PK, respectively. In the same experiments,
the mean Vmax values were 16±1 and 13±2 nmol/min×mg
of sample protein for the mitochondrial and cytosolic PK,
respectively.
In the case of the TX-JAM, the PK reaction was also
investigated by measuring the pyruvate formation via L-LDH
Fig. 3. pH profiles and the sensitivity to a variety of compounds of
mitochondrial and cytosolic pyruvate kinase activity. (A) Either TX-JAM
(0.5 mg protein, ●) or CF (0.2 mg protein,○) were incubated at 25 °C in 2 mL
of standard medium whose pH was adjusted to the indicated values with either
TRIS or HCl. Experimental conditions as in Fig. 1. PEP and ADP concentration
used were 5 and 0.25 mM, respectively. Bars represent the mean (±SD) of three
independent measurements. (B) PK activity was measured as described in Fig. 1,
by adding 0.1 mM PEP to either TX-JAM (0.5 mg protein) or CF (0.2 mg
protein) incubated at 25 °C in 2 mL of standard medium in the presence of
0.25 mM ADP, either in the absence or presence of the following compounds
(added to the sample 1 min before the substrate): malonate (10 mM), oxalate
(10 mM), mersalyl (0.1 mM), arsenite (1 mM), sulphite (2 mM), benzen-
tricarboxylic acid (BTA, 1 mM), bathophenanthroline (BF, 0.1 mM), α-CCN−
(1 mM), CAT (10 μM), oligomycin (OLIGO, 5 μM) and alanine (ALA, 5 mM).
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similar to those determined using the alternative assay described
above.
In order to confirm that the above reactions were catalyzed
by two different PKs, the pH and inhibition profiles of PK from
either mitochondrial or cytosol fraction were also investigated
fluorimetrically as above, with 5 mM PEP and 0.25 mM ADP
(Fig. 3A). The pH profiles differ one from another significantly:
PK activity in solubilized JAM was found to increase with pH
increase, reaching its maximum value over the pH range 7.00–
8.50, whereas when CF was used the maximum activity was
found at pH 6.25. The activity decreased at pH values over 6.75.
In both cases PK activities were roughly constant in the pH
range 7.5–8.5.The mitochondrial and cytosolic PK reactions, monitored at
0.1 mM PEP and 0.25 mM ADP, were also compared with
respect to their sensitivity to a variety of compounds, including
MALO (10 mM), oxalate (10 mM), arsenite (1 mM), sulphite
(2 mM), inhibitors of succinate, lactate, pyruvate and malate
dehydrogenase respectively. The thiol reagent mersalyl
(0.1 mM), benzentricarboxylic acid (BTA, 1 mM), the metal
complexing agent bathophenanthroline (BF, 0.1 mM), α-cyano-
4-hydroxycinnamate (α-CCN-, 1 mM) carboxyatractyloside
(CAT, 10 μM), inhibitors of somemitochondrial carriers [34,35],
OLIGO (5 μM), an inhibitor of ATP synthase and alanine (ALA,
5 mM) were also used (Fig. 3B). The inhibition profiles proved
to differ significantly one from another. For instance, MALO,
oxalate or mersalyl proved to inhibit specifically the mitochon-
drial PK, whereas BF, which was ineffective on the mitochon-
drial PK, inhibited by 45% the cytosolic enzyme.
3.2. PEP transport in JAM
Having established that JAM possess their own PK, located
in the inner mitochondrial compartments, we investigated
whether and how externally added PEP can enter mitochondria.
As an initial approach to this problem, swelling experiments
were carried out as in [36] (Fig. 4A). Intact coupled JAM
suspended in 0.14 M ammonium PEP showed spontaneous
swelling, at a rate lower than that found for 0.14 M ammonium
phosphate (NH4Pi), used as a control, this suggesting the
capability of PEP to enter JAM itself, in a proton-compensated
manner. The rate of JAM swelling in the isotonic ammonium
PEP solution proved to be inhibited in the presence of the non-
penetrant compound benzylmalonate (BEMA, 10 mM), this
suggesting that the uptake occurs in a carrier mediated manner.
As a control, it was confirmed that JAM do not swell in isotonic
sucrose solutions (Fig. 4A). In order to better investigate PEP
transport in JAM, by using substrate concentrations close to
physiological values, we resorted to a spectroscopic technique
which allows for measurement in organelles in which
metabolism is largely occurring. Thus, the capability of
externally added PEP to affect the red/ox state of the
intramitochondrial pyridine coenzymes was checked by
means of fluorimetric techniques, essentially as in [1] (Fig.
4B). Surprisingly, a decrease of fluorescence was found as a
result of PEP (1 mM) addition to JAM (0.5 mg protein),
reflecting intramitochondrial NAD(P)H oxidation. Notice that
no significant reduction of the mitochondrial NAD(P)+ was
found also as a result of PEP addition to JAM previously
incubated with the uncoupler FCCP (not shown). Since plant
mitochondria contain the alternative oxidase (AOX) which can
oxidize the newly synthesized NAD(P)H in the non-phosphor-
ylating alternative pathway [37], we checked whether the NAD
(P)H oxidation was dependent on AOX activity, perhaps
activated by PEP itself and/or by pyruvate, a powerful AOX
activator [38,39], produced in the PK reaction. The initial rate of
fluorescence decrease proved to be strongly inhibited by either
propyl gallate (Propyl-GALL, 2 mM) or salicylhydroxamate
(SHAM, 1 mM), inhibitors of the AOX [40–42] (50±4% and
30 ± 5% of the control, respectively, in three experiments
Fig. 4. Mitochondrial swelling in ammonium phosphoenolpyruvate solutions (A), fluorimetric investigation of the redox state of the intramitochondrial pyridine
nucleotides (B), Dixon plot of the inhibition by either propylgallate, SHAM or BEMA (C) and the dependence of the rate of intramitochondrial pyridine nucleotides
oxidation on increasing PEP concentrations (D). (A) JAM (1 mg protein) were rapidly added at 25 °C to 1.5 mL of 0.14 M ammonium phosphate (NH4Pi), 0.36 M
sucrose (SUCR), 0.14 M ammonium phosphoenolpyruvate (NH4PEP) or 0.14 M ammonium phosphoenolpyruvate plus 10 mM benzylmalonate (BEMA) and
mitochondrial swelling monitored as described in Materials and methods. The initial A546 nm of JAM suspended in sucrose was about 1.0. (B) JAM (0.5 mg protein)
were incubated at 25 °C in 2 mL of standard medium. At the arrows, PEP (1 mM) or pyruvate (PYR, 1 mM) (inset) were added in the absence (C) or presence of the
following inhibitors (added 1 min before the substrate): propyl gallate (Propyl-GALL, 2 mM), SHAM (1 mM), BEMA (10 mM), sulphite (SULPH, 2 mM), MALO
(10 mM), arsenite (ARS, 1 mM) or potassium cyanide (CN−, 1 mM). Mitochondrial pyridine nucleotide oxidation was followed fluorimetrically (λexc=334 nm;
λem=456 nm) as a function of time. The numbers along the curves are rates calculated as the tangent to the initial part of the experimental trace expressed as nmol NAD
(P)H oxidized/min×mg protein. (C) The rate of intramitochondrial pyridine nucleotide oxidation was measured after the addition of either 2.5 mM (a) or 1 mM and
10 mM PEP (b) to JAM (1 mg protein) either in the absence or presence of Propyl-GALL, SHAM or BEMA at the indicated concentrations. The inset in C, b is the plot
of 1/i against 1/[BEMA], where i=1−vi/vo; vi and vo being the rate of intramitochondrial pyridine nucleotide oxidation in the presence and in the absence of inhibitor,
respectively. (D) PEP was added at the indicated concentrations to JAM (1 mg protein). The rate of fluorescence decrease (vo), was measured as the tangent to the initial
part of the progress curves and expressed as nmol NAD(P)H oxidized/min×mg mitochondrial protein. Bars represent the mean (±SD) of three independent
measurements.
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penetrant compound BEMA (10 mM) proved to inhibit the
fluorescence change (35±4% of the control) which was
insensitive to either sulphite (2 mM) or MALO (10 mM),
whereas stimulation in intramitochondrial NAD(P)H oxidation
rate was found when arsenite (ARS, 1 mM), an inhibitor of
pyruvate dehydrogenase, was present (25±3% of the control).
A rate of about 200±10% of the control was found in the
presence of potassium cyanide (CN−, 1 mM), an inhibitor of
cytochrome oxidase (COX) (Fig. 4B). Similarly, in a control
experiment, NAD(P)H fluorescence decrease was found result-
ing from the addition of pyruvate (1 mM), the rate being
strongly inhibited by SHAM (1 mM), but stimulated by ARS
(1 mM) (inset of Fig. 4B). One possible explanation of these
findings is that PEP enters JAM and, subsequently, the
activation of AOX occurs by PEP itself, as shown by the
failure of MALO, which impairs pyruvate formation via PK, to
affect the rate of fluorescence decrease, and/or by pyruvate, thus
determining the cyanide-insensitive oxidation of intramitochon-
drial NAD(P)H.
In order to investigate whether the rate of fluorescence
decrease mirrors the rate of PEP uptake by JAM, control flux
analysis was carried out as in [35] (Fig. 4C). Thus, the
dependence of the rate of fluorescence decrease on increasing
concentrations of either Propyl-GALL or SHAM (Fig. 4C, a) at
2.5 mM PEP, or BEMA (Fig. 4C, b) at 1 mM and 10 mM PEP,
was investigated in the same experiment and the data plotted as
a Dixon plot. In the former case, the y intercepts of the lines
fitting the experimental points obtained in the presence of the
inhibitors did not coincide with the experimental values
obtained in their absence, this showing that the inhibitor-
sensitive step, i.e. AOX reaction, which determines intrami-
tochondrial NAD(P)H oxidation, is not rate limiting for the
measured process. Contrarily, in the presence of increasing
BEMA concentrations, the y intercepts of the lines fitting the
experimental points measured at both 1 and 10 mM PEP,
coincided with the experimental values measured in the absence
of inhibitor, as shown by the Dixon plot. In accordance with the
control flux analysis [35], this shows that BEMA-sensitive PEP
transport controls the rate of the measured process, i.e. the rate
of NAD(P)H fluorescence decrease reflects the rate of PEP
uptake by JAM. As expected in the light of the swelling
inhibition (Fig. 4A), BEMA proved to be a non-competitive
inhibitor of PEP uptake with a Ki value equal to 3 mM. The
data of Fig. 4C, b were also plotted as 1/i against 1/[Inhibitor],
where the fractional inhibition i is equal to 1−vi/vo (inset of
Fig. 4C, b). The y intercept was unity, showing that BEMA
can prevent PEP transport completely, thus indicating that no
PEP uptake by JAM can occur either by BEMA-insensitive
processes or by diffusion.
The dependence of the rate of NADH oxidation on increasing
PEP concentrations was investigated in JAM and saturation
characteristics were found with Km and Vmax values of 1.3 mM
and 8.9 nmol/min×mg of protein, respectively (Fig. 4D). In three
experiments, carried out with different preparations, themeanKm
and Vmax values were found to be 1.2±0.1 mM and 10±2 nmol/
min×mg of protein, respectively.The metabolite transport paradigm (see Ref. [35]) suggests
that net carbon uptake by mitochondria is accompanied by the
efflux of newly synthesized compounds. In order to determine
whether this applies in the case of PEP, in a first set of
experiments we checked for the efflux of pyruvate and ATP,
the products of the mitochondrial PK reaction, following PEP
uptake and metabolism by JAM (Fig. 5). In order to detect the
appearance of pyruvate in the extramitochondrial phase, JAM
(1 mg protein) were incubated with ROT (2 μg/2 mL),
inhibitor of complex I of the respiratory chain and with 10 mM
EGTA plus 5 μM DPI, in order to inhibit the external
mitochondrial NAD(P)H dehydrogenase, then the P.D.S.
consisting of L-LDH (1 e.u.) and NADH (20 μM), used at
low concentration in order to minimize external NAD(P)H
dehydrogenase activity [43], was added to the mitochondrial
suspension and NADH fluorescence measured (see Materials
and methods) (Fig. 5A). As a result of PEP (5 mM) addition, a
decrease in the NADH fluorescence was found, at a rate of
5.0 nmol NADH oxidized/min×mg protein, indicative of the
appearance of pyruvate in the extramitochondrial phase. In the
same experiment, we found that the mitochondrial PK inhibitor
MALO (10 mM) completely inhibited the appearance of
pyruvate, ruling out the possibility that pyruvate formation
occurred via the cytosolic PEP phosphatase shown to be
insensitive to MALO (inset to Fig. 1B, b).
In order to ascertain whether PEP can cause the efflux of
mitochondrial ATP, JAM (1 mg protein) were incubated with
0.1 mM Ap5A and with 5 mM succinate, used to inhibit ADK
and to energize mitochondria, respectively, thus favoring the
membrane potential dependent ATP efflux, and ATP appearance
was measured as above. ATP concentration outside mitochon-
dria was negligible since no fluorescence increase occurred
when ATP D.S. was added to the mitochondrial suspension. As
a result of PEP (5 mM) addition, an increase in NADPH
fluorescence was found, at a rate equal to 2.7 nmol NADP+
reduced/min×mg protein, indicating the appearance of ATP in
the extramitochondrial phase (Fig. 5B).
A possible explanation of these findings is that PEP, which
can enter JAM itself, forms ATP and pyruvate in the matrix
because of the presence of the mitochondrial PK and
endogenous ADP; newly synthesized ATP and pyruvate can,
in turn, get to the extramitochondrial phase in exchange with
further PEP (see Scheme 1).
One could argue that ATP efflux could depend also on the
presence of ADP formed outside mitochondria by the ATP D.
S. when revealing ATP efflux. To gain further insight into this
point as well as to ascertain whether the effluxed ATP derives
from substrate level phosphorylation, we directly checked the
capability of PEP to synthesize ATP from the intramitochon-
drial ADP, via HPLC analysis. In this case we incubated JAM
with Ap5A (0.1 mM). In a typical experiment (Fig. 5C) we
measured the amounts of ADP and ATP in the pellet and
supernatant of a mitochondrial suspension incubated or not
with 5 mM PEP. The addition of PEP to JAM, either in the
absence or presence of OLIGO (2.5 μg/1 mL) used to inhibit
the ATP synthase, resulted in a decrease in the mitochondrial
content of both ADP and ATP [Δ(ADPIN+ATPIN)], and in the
Fig. 5. Appearance of pyruvate and ATP induced by PEP addition to JAM and
HPLC analysis of ADP and ATP levels after PEP addition to JAM. (A, B) JAM
(1 mg protein) were suspended at 25 °C in 2 mL of standard medium in the
presence of either (A) the P.D.S. (20 μM NADH plus 1 e.u. L-LDH) plus ROT
(2 μg), EGTA (10 mM) and diphenyleneiodonium (DPI, 5 μM), or (B) the ATP
D.S. plus Ap5A (0.1 mM) and succinate (5 mM). At the arrow PEP (5 mM) was
added in the absence (C) or presence of the following inhibitors (added 1 min
before the substrate): MALO (10 mM), phenylpyruvate (PhePYR, 10 mM),
α-cyano-4-hydroxycinnamate (α-CCN−LOW, 25 μM), α-CCN
−
HIGH, (1 mM) or
carboxyatractyloside (CAT, 10 μM). Externally added pyridine nucleotide
oxidation or reduction was followed fluorimetrically (λexc=334 nm; λem=
456 nm) as a function of time. The numbers give the rate of fluorescence
changes measured as tangents to the initial part of the progress curves and
expressed as nmol NADH oxidized (NADP+ reduced)/min×mg mitochondrial
protein. (C) JAM (1 mg protein) were incubated at 25 °C in 1 mL of standard
medium. The amounts of ADP and of ATP, were measured in neutralized
perchloric acid extracts of both the pellet and supernatant (insets) fractions of
JAM, as described in Materials and methods. Where indicated, PEP (5 mM) was
pre-incubated with JAM.
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ATPOUT/Δ(ADPIN+ATPIN) ratio close to 1. Even though the
endogenous nucleotide content of the JAM preparations were
significantly different, a ratio close to 1 was found in three
different experiments (Table 1). Notice that HPLC allows for
measurements of ATP concentrations lower than those that can
be monitored fluorimetrically.
Both to ascertain that pyruvate or ATP efflux due to externally
added PEP occurs in a carrier-mediated manner and to rule out
the involvement of the pyruvate and ADP/ATP carriers in the
transport, we checked the sensitivity of the PEP-dependent
metabolite efflux to different compounds that cannot enter
mitochondria (Fig. 5A, B). In particular, the PEP-dependent
pyruvate efflux does not occur via the pyruvate carrier since it
was not inhibited by 25 µM α-CCN– (αCCN−LOW), a potent
inhibitor of the monocarboxylate carrier [34], which proved to
completely block pyruvate uptake by JAM via the monocarbo-
xylate carrier, monitored fluorimetrically as in [1] (not shown).
That PEP dependent ATP efflux occurs via the ADP/ATP carrier
is ruled out since it was inhibited by 1 mM α-CCN (αCCNHIGH)
which had no effect on the ADP/ATP carrier measured
fluorimetrically as reported in Materials and methods (not
shown). Moreover, either phenylpyruvate (PhePYR; 10 mM) or
carboxyatractyloside (CAT; 10 μM), proved to inhibit ATP but
not pyruvate efflux due to PEP addition to JAM, thus showing
that PEP/pyruvate and PEP/ATP exchanges occur in a different
manner (Fig. 5A, B).
In the same experiment we found that BEMA (10 mM),
which inhibits both swelling and PEP uptake, was ineffective in
inhibiting either pyruvate or ATP efflux, whereas BTA (1 mM)
completely inhibited both of them (not shown). The differences
between the inhibition profiles show that pyruvate and ATP
appearance outside JAM in exchange with PEP take place via
two different carriers, themselves separate from that mediating
PEP uptake.
To confirm that the rates of externally added NADH
oxidation/NADP+ reduction, due to PEP addition in the
presence of P.D.S. and ATP D.S. respectively, mirror that of
pyruvate and ATP transport, control flux analysis [34] was
carried out as above, by investigating the dependence of the
rate of either fluorescence decrease or increase on increasing
α-CCN− (Fig. 6A, a) or CAT (Fig. 6B, a) concentrations,
respectively, at 0.5 and 5 mM PEP. α-CCN− proved to be a
competitive inhibitor of the rate of pyruvate appearance with
Ki value equal to 0.7 mM; CAT proved to inhibit ATP
appearance in a non-competitive manner with Ki value equal
to 6 μM. To confirm that ATP efflux does not occur via the
ADP/ATP carrier, we showed that CAT is a competitive
inhibitor of the ADP/ATP carrier, with a Ki value equal to
6 μM, (inset of Fig. 6B, a). Control flux analysis carried out as
above shows that the rate of NADH oxidation/NADP+
reduction reflects the rate of the PEP/pyruvate and PEP/ATP
exchange, respectively.
The dependence of the rate of PEP/pyruvate and PEP/ATP
antiports on increasing PEP concentrations was measured and
results analyzed by means of a Michaelis–Menten plot (Fig.
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to 5 and 3 nmol/min×mg mitochondrial protein, respectively.
In three experiments, carried out with different preparations,
the mean Km values were found to be 200±10 and 500±
20 μM, whereas the mean Vmax values were found to be 5±0.3
and 3±0.3 nmol/min×mg mitochondrial protein, for the PEP/
pyruvate and PEP/ATP antiporters, respectively. As a control,
the ADP/ATP exchange rate was measured in the same
experiment at increasing ADP concentrations and the experi-
mental data analyzed by means of a Michaelis–Menten plot
(inset of Fig. 6B, b). Km and Vmax values of 1 μM and
10 nmol/min×mg mitochondrial protein, respectively, were
found.
To gain further insight into the mechanism of PEP uptake by
JAM as well as into the physiological role of the mitochondrial
PEP metabolism, the capability of PEP to cause the efflux of
several compounds other than pyruvate and ATP, was checked.
In initial investigations, the appearance of malate, oxaloacetate
(OAA) and citrate outside mitochondria was monitored
photometrically or fluorimetrically by using specific metabolite
detecting systems (see Materials and methods) (Fig. 7). The
concentration of OAA, citrate and malate outside mitochondria
were negligible since no change in the NAD(P)H fluorescence
or absorbance was found in the presence of O.D.S., C.D.S. and
M.D.S., respectively. As a result of 5 mM PEP addition, OAA
(Fig. 7A), citrate (Fig. 7B) but not malate (Fig. 7C) appearance
was found as shown by the decrease of NADH fluorescence, in
the case of OAA and citrate, and by the lack of increase of the
NADPH absorbance in the case of malate. The rate of citrate
efflux (4 nmol/min×mg protein) was obtained by subtracting
the rate of OAA efflux previously measured (6 nmol/min×mg
protein), from the rate found in the presence of C.D.S.
(10 nmol/min×mg protein) (see Materials and methods).
Phenylsuccinate (PheSUCC, 10 mM) and BTA (1 mM) were
found to inhibit the appearance of oxaloacetate and citrate,
respectively. Interestingly, BTA had no effect on OAA
appearance rate, thus suggesting the involvement of two
different transport processes for OAA and citrate efflux (Fig.
7A, B). In a control experiment, the addition of succinate
(5 mM) to JAM incubated with M.D.S., produced a fast
increase in NADPH absorbance due to malate efflux in the
extramitochondrial phase in exchange with succinate, via the
dicarboxylate carrier [1] (Fig. 7C).
4. Discussion
In this paper we show for the first time that PEP can be
transported into plant mitochondria, in particular those from
Jerusalem artichoke tubers, and be metabolized therein. The
sequence of events involved in PEP metabolism includes PEP
uptake by mitochondria, pyruvate and ATP synthesis inside
mitochondria due to the novel mitochondrial PK, oxidation of
the intramitochondrial NAD(P)H due to the activation of the
AOX, PEP/pyruvate and PEP/ATP antiports which are assumed
to take place via two separate carriers distinct from the pyruvate
and the ADP/ATP carriers. These points will be discussed
separately below.
Fig. 6. Dixon plot of the inhibition by αCCN− and CAT of the rate of pyruvate and ATP appearance due to externally added PEP. Dependence of PEP/pyruvate and
PEP/ATP antiports on increasing PEP concentrations. JAM (1 mg protein) were incubated at 25 °C in 2 mL of standard medium. The rate of pyruvate (A) or ATP (B)
appearance in the extramitochondrial phase was measured as described in Fig. 5. PEP (0.5 mM, or 5 mM) (A, a; B, a) or ADP (5 μM, or 50 μM) (inset of B, a) were
added either in the absence or presence of α-CCN− or CATat the indicated concentrations. The rate (vo), measured as the tangent to the initial part of the progress curve,
is expressed as nmol NADH oxidized (NADP+ reduced)/min×mg mitochondrial protein. Either PEP (A b; B, b) or ADP (inset of B, b) were added to JAM (1 mg
protein) at the indicated concentrations and the rate of NADH oxidation (A, b)/NADP+ reduction (B, b), reflecting the rate of pyruvate/ATP appearance, respectively,
was measured as the tangent to the initial part of the progress curves and expressed as nmol/min×mg mitochondrial protein. Bars represent the mean (±SD) of three
independent measurements.
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spectroscopic techniques under conditions in which mitochon-
drial metabolism is mostly active, thus allowing for monitoring
mitochondrial reactions and the traffic of newly synthesized
substrates across the mitochondrial membrane. JAM can take
up PEP with net carbon uptake in a proton-compensatedmanner. This was first shown by the observed swelling in
isotonic solutions of ammonium PEP which itself indicates that
PEP uptake is proton-compensated (Scheme 1). Indication in
favor of a carrier mediated transport derives from the inhibition
of swelling due to BEMA which cannot enter JAM. Definitive
confirmation is given by the occurrence of the hyperbolic
Fig. 7. Appearance of oxaloacetate and citrate in the extramitochondrial phase
induced by the addition of PEP to JAM. JAM (1 mg protein) was suspended at
25 °C in 2 mL of standard medium in the presence of either (A) the oxaloacetate
detecting system (O.D.S., 20 μMNADH plus 1 e.u. malate dehydrogenase), (B)
the citrate detecting system (consisting of O.D.S. plus 1 e.u. citrate lyase, 1 mM
ATP and 1 mM coenzyme A), or (C) the malate detecting system (200 μM
NADP+ plus 0.2 e.u. malic enzyme). In A and B rotenone (2 μg), EGTA
(10 mM) and DPI (5 μM) were added to the mitochondrial suspension before the
metabolite detecting system. At the arrow phosphoenolpyruvate (PEP, 5 mM)
was added in the absence (C) or presence of phenylsuccinate (PheSUCC,
10 mM) or BTA (1 mM). In C, the substrate (S), i.e. PEP or succinate (SUCC),
both 5 mM, was added at the arrow. Pyridine nucleotide oxidation was followed
fluorimetrically as a function of time. The numbers give the rate of fluorescence
decrease (λexc=334 nm; λem=456 nm) (A, B) or absorbance increase
(λ=334 nm) (C) measured as tangents to the initial part of the progress curves
and expressed as nmol NADH oxidized (NADP+ reduced)/min×mg mitochon-
drial protein.
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fluorimetrically investigated. Indeed, we have been forced to
use a non-traditional approach in investigating PEP uptake. As
opposed to the expected increase of NAD(P)H fluorescence due
to the NAD(P)+ reduction arising from the intramitochondrial
metabolism of the newly synthesized pyruvate, as a result ofPEP addition to JAM we observe intramitochondrial NAD(P)H
oxidation due to the activation of AOX as shown by the
capability of both Propyl-GALL and SHAM, AOX inhibitors,
to inhibit this process (Fig. 4). Nonetheless, in spite of the four
steps involved in this process, i.e. PEP uptake, the PK reaction,
AOX activation by PEP and pyruvate with the consequent
intramitochondrial NAD(P)H oxidation, we maintain that the
decrease of fluorescence mirrors the transport step, its rate being
the limiting step of the entire process, as shown by applying
control strength criterion (Fig. 4C, b). Consistently, we have
found that no inhibition in the rate of NAD(P)H oxidation takes
place in a definite low concentration range of both Propyl-
GALL and SHAM (Fig. 4C, a). Malonate which can completely
inhibit PK activity (Fig. 1B, a), was ineffective on the rate of
PEP-dependent NAD(P)H oxidation, showing that PEP itself is
an AOX activator (Fig. 4B). Notice that the measured rate
derives from the balance between the NAD(P)H producing and
consuming reactions, as indicated by the increase of the
oxidation rate observed in the presence of arsenite and cyanide,
inhibitors of the pyruvate dehydrogenase complex and of the
COX respectively.
The results that we have reported show the existence of a
mitochondrial PK (see Fig. 1). Such a conclusion derives from
the immunological analysis reported in Fig. 1A, confirmed by
kinetic studies in which we show saturation characteristics for
the reaction in solubilized JAM. In this case we avoid
assaying PK routinely via L-LDH and NADH, since NADH at
the used concentration, is rapidly oxidized by the external
NAD(P)H dehydrogenase (inset to Fig. 1B, a). In contrast, the
fluorimetric method used to monitor ATP appearance allows
for the measurement at micromolar concentration of NADPH
which is not oxidized by the external NAD(P)H dehydrogen-
ase as already shown in [43] and as found in a control
experiment carried out with JAM, not shown here. Since the
putative PK activity can be assayed only in solubilized JAM,
PK must be localized on the inner side of the mitochondrial
inner membrane or in the matrix space. Moreover ATP
synthesis measured via HPLC in the mitochondria incubated
only with PEP in the absence of external ADP is not consistent
with PK localization in the external compartments (Fig. 5C and
Table 1).
The discovery of the mitochondrial PK, as derived from both
immunological and functional studies, is consistent with the
results we obtained from the TAIR (Arabidopsis Information
Resource) gene search in which two matches correspond to PK
isoforms predicted by Target P program to be located in
mitochondria. Thus, at present we cannot rule out that the
measured PK activity is due to two mitochondrial isoforms.
Nonetheless, it/they is/are different from that/those investigated
in the cytosolic fraction as shown by the different inhibition and
pH profiles.
Discussion of the role of mitochondrial PK can only be
speculative. Having established via HPLC that the intramito-
chondrial ADP amount decreases with no ADP found outside
JAM (Table 1), we must assume that the mitochondrial PEP
metabolism results in a decrease in the rate of the isocitrate
dehydrogenase reaction, which is highly dependent on ADP
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cycle; on the other hand, we show additional AOX activation
due to PEP itself (see Scheme 1), which promotes intramito-
chondrial NAD(P)H oxidation also in the presence of the PK
inhibitor malonate. Thus it is proposed that PEP and pyruvate
are together AOX activators, with PEP involved in the AOX
puzzle (see [44]).
This paper gives a first indication in favor of the occurrence of
two novel carriers: the PEP/pyruvate and PEP/ATP antiporters
(Figs. 5 and 6).When studying both PEP/ATP and PEP/pyruvate
exchanges, control flux analysis application (see [35]) showed
that the measured changes in fluorescence mirror the rate of
substrates transport (Fig. 6A, a; B, a). Thus if the situation in
vivo is similar to that in vitro, then the metabolism of PEP is
regulated by transport processes. Moreover, we show that PEP
antiporters differ from each other, from the PEP symporter and
from the pyruvate and ADP/ATP carriers on the basis of the
different sensitivity to certain non-penetrant compounds.
At present, the role of effluxed pyruvate in the cytoplasm
remains unclear; the possibility should be considered that it
may participate in the biosynthesis of storage proteins (see
Scheme 1). The effluxed ATP is assumed to enter the cytosolic
pool, thus contributing to energy metabolism.
PEP might play a major role in directing carbohydrate
towards plastidic fatty acid biosynthesis versus the mitochon-
drial ATP production and organic acid required for aminoacid
inter-conversion in support of storage protein biosynthesis [10].
This paper opens new scenarios to PEP plant metabolism.
Indeed, if we assume that the cytosolic PEP concentration is in
the millimolar range as reported in mesophyll cells of spinach
[45] then the Km values for PEP uptake are consistent with the
physiological occurrence of PEP mitochondrial uptake and
metabolism.
We suggest that, as a result of the PEP metabolism via the
putative mitochondrial PK, reduction in isocitrate dehydrogen-
ase activity could occur (see above), with consequent increase
of matrix citrate concentration which could determine its efflux
outside mitochondria. Consistently, in initial experiments we
have found that JAM incubated with PEP can export citrate and
oxaloacetate to the extramitochondrial phase (Fig. 7) thus also
providing a novel pathway accounting for ammonia incorpora-
tion and fatty acid synthesis (see Scheme 1).
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